Skip to main content
Premium Trial:

Request an Annual Quote

Life Tech Adds New Contest to its Grand Challenge

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today announced it has expanded its Life Grand Challenges competition to include a contest to use the 5500 Series SOLiD platform to sequence the genome and all RNA content derived from a single cancer cell.

The latest $1 million challenge, which is part of the $7 million contest announced in December, is "to unlock science's ability to understand the cell-to-cell genetic differences within a tumor," Life Tech said in a statement. The first three challenges ae focused on Ion semiconductor sequencing using the Ion Torrent platform. The fourth challenge is focused on SOLiD sequencing and the remaining three challenges will be related to other Life Technologies products and will be announced later in 2011, the firm said.

While the SOLiD has been used to sequence the entire transcriptome of a single mouse cell, the entire genome of one cell has yet to be sequenced, the company noted.

"Successful achievement of this latest Grand Challenge will, therefore, double what is currently possible by sequencing both the entire genome and all RNA, including mRNA, microRNAs and other types of RNA molecules expressed in a single cancer cell, using the SOLiD System," Life Tech said.

Results will need to be validated using an alternative method, such as quantitative PCR or capillary electrophoresis sequencing.

The judges for this challenge are Tim Hunkapiller, founder, president and CSO of Discovery Biosciences; Kai Lao, principal scientist of molecular biology for Life Tech; Joe Beechem, head of advanced research of single molecule sequencing for the Genetic Systems Division of Life Tech; and Mahendra Rao, vice president of R&D in stem cells and regenerative medicine for Life Tech.

The company will release additional information about the challenge, including terms and conditions, by the end of the first quarter.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.